 |
Tell a Friend About:
Return To Article
Community Oncology Explores Pitched Debate Over Anemia-Fighting Drugs
The June issue of Elsevier's Community Oncology takes an in-depth look at the charge that ESAs, generally considered vital to cancer patients' quality of life, are overprescribed for profit.
The June issue of Elsevier's Community Oncology takes an in-depth look at the charge that ESAs, generally considered vital to cancer patients' quality of life, are overprescribed for profit.
Return To Article
| © 2008 BrightSurf.com |